Background
Methods
Statistical analysis
Results
Characteristics | Clamp group (n = 22) | Control group (n = 25) | P value |
---|---|---|---|
Age (year), mean (SD) | 31.0±3.62 | 30.9±3.65 | .907 |
BMI (kg/m2),mean (SD) | 22.5±1.66 | 22.2±1.85 | .600 |
Gravidity, n (%) | .949 | ||
≤2 | 13 (59.1%) | 15 (60%) | |
≥3 | 9 (40.9%) | 10 (40%) | |
Parity, n (%) | .753 | ||
<2 | 14 (63.6%) | 17 (68%) | |
≥2 | 8 (36.4%) | 8 (32%) | |
Pregnancy, n (%) | .553 | ||
Single | 18 (81.8%) | 22 (88%) | |
Twins | 4 (18.2%) | 3 (12%) | |
Delivery method, n (%) | .706 | ||
Cesarean delivery | 10 (45.5%) | 10 (40%) | |
Vaginal delivery | 12 (54.5%) | 15 (60%) | |
Scarred uterus, n (%) | 8 (36.4%) | 6 (24%) | .355 |
ART n (%) | 7 (31.8%) | 5 (20%) | .354 |
PROM n (%) | 7 (31.8%) | 8 (32%) | .989 |
ICP n (%) | 2 (9.1%) | 3 (12%) | .746 |
Uterotonic contraindications, n (%) | 12 (54.5%) | 10 (40%) | .319 |
Abnormal placenta, n (%) | .749 | ||
Placental adhesion | 6 (27.3%) | 8 (32%) | |
Low placenta | 2 (9.1%) | 1 (4%) | |
Placenta previa | 2 (9.1%) | 2 (8%) | |
Surgical measures in groups, n (%) | |||
Repair of lower uterus | 6 (27.3%) | 6 (24%) | .651 |
Uterine binding | 6 (27.3%) | 7 (28%) | .956 |
Uterine cavity packing | 8 (37.4%) | 3 (12%) | .105 |
Uterine suture | 1 (4.5%) | 6 (24%) | .049a |
Ligation of uterine artery | 0 | 3 (12%) | .046a |
Newborn weight (g), mean (SD) | 2832±1067 | 3060±1039 | .706 |
Clamp group (n = 22) | Control group (n = 25) | P value | |
---|---|---|---|
Bleeding in labor (n = 27) | (n = 12) | (n = 15) | |
Intrapartum blood loss (g), mean (SD) | 656.2±72.79 | 811.8±86.07 | .001a |
Bleeding in the ward (n = 20) | (n = 10) | (n = 10) | |
Blood loss in 30 min (g), mean (SD) | 42.8±6.60 | 126.3±86.97 | .007a |
Blood loss in 30~60 min (g), mean (SD) | 10.4±1.96 | 21.88±2.30 | .000a |
Hemoglobin (g/L),mean (SD) | |||
Preoperative Hb | 119±4.10 | 121.4±4.19 | .058 |
Postoperative Hb | 96.9±8.33 | 96.1±7.39 | .718 |
Blood transfusion, n(%) | 2 (9.1%) | 3 (12%) | .746 |
Repeated usage of uterotonic, n(%) | .001a | ||
≤2 (type/time) | 18 (81.8%) | 9 (36%) | |
≥3 (type/time) | 4 (18.2%) | 16 (64%) | |
Uterotonic side effect, n(%) | 4 (18.2%) | 12 (48%) | .031a |
Clamp complications, n(%) | 0 | – | |
Surgical procedures, n(%) | |||
Intrauterine Bakri balloon | 1 (4.5%) | 3 (12%) | .36a |
Urgent UAE | 1 (4.5%) | 1 (4.0%) | .93a |
Laparotomy | 0 | 0 | – |
Hospital stay (days), mean (SD) | 4.1±1.57 | 3.8±1.61 | .535 |